Circulating triglyceride levels are dictated not only by dietary intake but also by hepatic triglyceride production, which is elevated in NAFLD. This suggests that NAFLD may be exerting its negative effects on vascular function indirectly via increasing blood triglyceride levels. As a result, we hypothesized that the elevated liver fat levels in obesity would be linked to aortic stiffness, and that effect would, at least in part, be mediated indirectly via increasing serum triglyceride levels. Should © 2015 American Heart Association, Inc. Objective-To investigate the relationship between hepatic fat content, circulating triglyceride levels and aortic stiffness in adult and childhood obesity. Approach and Results-Seventy-seven adults and 18 children across a wide range of body mass index (18.5-52.6 kg/ m 2; percentile 8-100) with no identifiable cardiac risk factors underwent; 1H-magnetic resonance spectroscopy to quantify hepatic fat content and magnetic resonance imaging to assess aortic pulse wave velocity (PWV) and regional distensibility. In adults, multivariable regression showed age (β=0.09; P=0.02), liver fat (β=2.5; P=0.04), and serum triglyceride (β=0.47; P=0.01) to be independent predictors of PWV. Age and blood pressure-adjusted, moderated regression showed that 43% of the total negative effect of hepatic fat on PWV is attributable to indirect effects via increased triglyceride (P=0.005). In addition, regional distensibility was positively correlated with hepatic fat (ascending; r=−0.35; descending, r=−0.23; abdominal, r=−0.41; all P<0.001). Similar to that seen in adults, PWV (r=0.72; P<0.001) and abdominal regional distensibility (r=−0.52; P<0.001) were correlated with liver fat in children. Conclusions-Increasing age, liver fat, and triglyceride are all related to increased aortic stiffness in adults. Even when controlling for the effects of age and blood pressure, hepatic fat has a negative effect on PWV, with substantial indirect effect occurring via increased circulating triglyceride level. This relationship between hepatic fat and aortic stiffness occurs early in the obesity process and is also seen in children. As such, hepatic fat content is a potential therapeutic target to treat the elevated vascular risk in obesity. 
A ortic pulse wave velocity (PWV) is a useful, well-validated, clinical measure of central arterial stiffness and has been shown to be predictive of increased mortality, coronary heart disease, and stroke in multiple patient groups. [1] [2] [3] Obesity, even in the absence of the metabolic syndrome, is associated with increased PWV, 4 and changes in adipose levels over time are emerging as an important modifiable determinants of arterial aging, with large epidemiological studies showing ≈12% of body mass index-related increase in cardiovascular disease being attributable to adipose mediated increases in PWV. 5 The mechanisms by which obesity causes vascular stiffness are not fully elucidated, but the fact that obesity is strongly related to non alcoholic fatty liver disease (NAFLD) and that NAFLD is an independent risk factor for arterial stiffness [6] [7] [8] make it likely that this is an important process by which obesity impairs arterial elastic function. In support of this, in addition to the association with the metabolic syndrome and diabetes mellitus, NAFLD is thought to independently promote coronary vascular disease and predicts greater carotid intima-media thickness, 9 as well as impaired endothelial function and lower adiponectin levels. 10 Whether a link exists between liver fat deposition and vascular stiffness in children remains unknown, but given the major increase in childhood obesity and childhood NAFLD is certainly worthy of investigation ( Figure 1 ).
One potential pathway through which NAFLD could act to impair arterial function is by increasing circulating triglyceride levels, which is known to impair aortic elastic function.
there be a strong liver fat-arterial stiffening pathway, this would be an attractive potential therapeutic target to reduce obesity-related morbidity and cardiovascular mortality.
To investigate this, 77 adults and 18 children underwent magnetic resonance imaging assessment 12 of aortic PWV, 13 regional aortic distensibility (AD) 14 and abdominal visceral fat, 1H magnetic resonance spectroscopy assessment of liver fat content, dual-energy x-ray absorptiometry assessment of total fat mass, and fasting blood tests for serum triglyceride levels.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
A summary of the anthropometric data for the adult and childhood study groups is shown in Table 1 .
Adult Cohort
Hepatic Fat Content in Adults As expected, liver fat level was strongly positively correlated with abdominal visceral fat (r=0.81; P<0.001), total fat mass (r=0.60; P<0.001), and serum triglyceride levels (r=0.60; P<0.001) and also moderately correlated with markers of insulin resistance (glucose mmol/L: r=0. 30 Table 3 ).
Stepwise multivariable regression of these variables revealed showed triglyceride (β=3.6; P=0.009) and liver fat (β=2.5; P=0.008) to be independent predictors of increased PWV in this model (overall R 2 of the model 0.42; P<0.001; Table 4 ). To further explore the relationship between PWV, liver fat, and triglyceride, age and systolic blood pressure-adjusted moderated multiple regression was performed (dependent variable PWV, independent variable hepatic fat, moderator triglyceride; Figure 2 ; Table 5 ). In this model, liver fat was positively related to PWV (c pathway; β=2.96; P<0.001), liver fat was positively related to serum triglyceride level (a pathway; β=0.49; P<0.001), and that the mediator triglyceride was positively related to PWV (b pathway; β=2.52; P=0.0045). As the a and b pathways were significant, mediation analysis was tested using 10 000 bootstrap resamples to generate a 95% confidence interval (bias corrected) of the indirect effect. 15 This confirmed the mediating role of triglyceride in the relationship between liver fat and PWV (β=0.12; 95% confidence interval, 0.15-3.3). As the direct effect of liver fat remained significant (β=1.7; P=0.03), this suggests partial mediation. Overall, 42% of the total negative effect of liver fat on PWV are attributable to the indirect effects through increasing serum triglyceride in this model ( Figure 2 ; Table 4 ). 
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Childhood Cohort
Hepatic Fat Content in Children Similar pattern that was seen in adults was observed in children, with liver fat level being strongly positively correlated with abdominal visceral fat (r=0.77; P<0.001), subcutaneous fat mass (r=0.78; P<0.001), and serum triglyceride levels (r=0.60; P<0.001; Table 2 ).
Aortic Stiffness in Children
Again, similar to that seen in adults, aortic PWV in children was correlated positively with subcutaneous fat mass (r=0.57; 
Discussion
NAFLD is the most common cause of chronic liver, and its prevalence is increasing worldwide. 7 NAFLD is considered the hepatic manifestation of metabolic syndrome and is associated commonly with metabolic risk factors, including obesity, insulin resistance, and dyslipidemia. Considering the rising prevalence of obesity and type 2 diabetes mellitus worldwide, NAFLD is becoming a major global health problem. It is now becoming clear that NAFLD is an independent risk factor for arterial stiffness, 6 but the mechanisms by which increased hepatic fat act to impair aortic elastic function remain unclear. We have shown here that aortic stiffness, measured with both PWV and AD, are strongly related to hepatic fat content in adults and, for the first time in children. We have also shown that a substantial proportion of the negative effects of liver fat on PWV are likely to be mediated via increased circulating triglyceride levels, suggesting a significant liver fat-arterial stiffening pathway exists.
Hepatic Fat Content, Triglycerides, and Aortic Stiffness
Triglyceride are primarily synthesized in the liver and transferred to adipose tissue for storage. However, once triglyceride homeostasis is disrupted, this eventually results in ectopic fat accumulation in the liver. The amount of liver fat is dictated by the balance between input processes (de novo lipogenesis and fatty acid uptake) and output processes (β-oxidation of fatty acid and triglyceride export). Dysregulation of this homeostasis leads to abnormal triglyceride accumulation and increased hepatic triglyceride output. 16 Although we have shown here that hepatic fat content predicts arterial stiffness, a direct negative effect of hepatic fat on aortic elastic function seems unlikely given the lack of spatial colocalization. As a result, we hypothesize that a major component of the observed negative effect is mediated via increased hepatic triglyceride output. This seems plausible given the fact that artificially increasing triglyceride levels not only impairs aortic function through the induction of endothelial dysfunction 17 but also results in elevated PWV 6 and reduced distensibility in a pattern similar to that seen in obesity. 11 The relative contributions of liver triglyceride output and dietary intake of triglyceride to arterial stiffness are less clear, but using moderate multivariable regression, we have shown in this study that ≈43% of the increase in PWV that is attributable to elevated liver fat occurs via indirect effects through elevated triglyceride levels.
Hepatic Fat Content, Inflammation, and Aortic Stiffness
Although the remaining indirect effects of elevated liver fat are unmeasured in this study, the link between NAFLD and low-grade inflammation 18 makes it likely that this also underpins some of the observed relationship between liver fat and aortic stiffness. In line with this, C-reactive protein, interleukin-6 and tumor necrosis factor-α levels have all been found to correlate with both NAFLD and aortic stiffness.
18-21
NAFLD and Aortic Stiffness in Children
Although it is becoming established that NAFLD is predictive of central arterial stiffness in adults, the data in childhood are conflicted. Several studies show increased carotid intimamedia thickness in those with liver steatosis, 22, 23 but others have showed that no relation was found with carotid intimamedia thickness or arterial wall stiffness. [24] [25] [26] Using magnetic resonance imaging to measure central aortic elastic function, we have shown here that hepatic fat is strongly associated with aortic PWV and with abdominal AD, both suggesting that liver fat plays a role in reducing aortic elastic function in children. The reasons behind the discrepancy in the literature may be that the majority of previous studies have recorded peripheral rather than central arterial elastic function. Another explanation may well lie in the pattern of aortic stiffness observed here in children.
Pattern of Aortic Stiffness
In this study, we showed reduced distensibility only in the DDA in children, which confirms previous studies. [27] [28] [29] This suggests that the DDA is the first area to become affected by obesity and could explain why studies of peripheral arterial beds have shown conflicting data. The reasons for this pattern are unclear but may be related to an inherent susceptibility of the abdominal section of the aorta to the increases in abdominal visceral and liver fat. Given the fact that the aorta is not a heterogeneous structure, with the elastin:collagen ratio decreasing along its length, and the fact that vascular wall compliance depends on the relative ratios of collagen and elastin, the 2 major wall structural proteins, 30 it is not surprising that the processes in obesity that are causing increased stiffness would have the earliest and greatest impact on the distal aorta, which has been shown in adult obesity studies.
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Significance
Aortic stiffness is an independent risk factor for incident hypertension, cardiovascular disease, and stroke, 1 and it is associated with age-related physical 32 and cognitive decline. It has also recently been shown that changes in adipose levels are an important determinant of arterial aging with ≈12% of body mass index-related increased cardiovascular disease attributable to arterial stiffness. 5 Given the fact that we have shown a strong relationship between liver fat, triglyceride, and arterial stiffening, this liver fat-arterial stiffening pathway may be a potential target to reduce morbidity and cardiovascular mortality in obesity. The presence of this relationship in children suggests that this negative pathway exists early in obesity process. Given the fact that liver fat is a modifiable substrate that can be quickly normalized with dietary intervention, 33 this may well become a target to ameliorate, or even prevent, vascular risk in obesity.
Limitations
This study is a relatively small cross-sectional study and does not examine the changes over time related to liver fat, triglyceride, and PWV and does not investigate the effect of changes in liver fat or triglyceride. Insulin resistance was measured using fasting glucose and insulin levels. Although likely to be important, this study did not measure NAFLD-secreted inflammatory biomarkers, only fat content. A larger study is need to confirm these findings and investigate additional mechanisms.
Conclusions
Although obesity is known to be associated with aortic stiffness, the mechanism that underlie this are not well understood. Here, we have shown that, in obesity, it is the distribution of fat deposition that is more important than the absolute volume of excess adipose tissue in determining aortic elastic function. In this study, liver fat content, rather than total fat or abdominal visceral fat, emerges as the most powerful predictor of aortic stiffness. In addition, we have shown that a significant proportion of the negative effects of hepatic fat on arterial stiffness occurs via increasing circulating triglyceride levels, suggesting a liver fatarterial stiffening pathway. Furthermore, we have shown that aortic stiffness occurs early, in childhood obesity, and is also related to increased hepatic fat. This not only highlights the fact that excess hepatic fat deposition is important in determining vascular function but also implies that hepatic fat is a potential therapeutic target to treat the elevated vascular risk in obesity.
